Your browser doesn't support javascript.
loading
Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations.
Selvavinayagam, Sivaprakasam T; Sankar, Sathish; Yong, Yean K; Murugesan, Amudhan; Suvaithenamudhan, Suvaiyarasan; Hemashree, Kannan; Rajeshkumar, Manivannan; Kumaresan, Anandhazhvar; Pandey, Ramendra P; Shanmugam, Saravanan; Arthydevi, Parthiban; Kumar, Masilamani Senthil; Gopalan, Natarajan; Kannan, Meganathan; Cheedarla, Narayanaiah; Tan, Hong Y; Zhang, Ying; Larsson, Marie; Balakrishnan, Pachamuthu; Velu, Vijayakumar; Byrareddy, Siddappa N; Shankar, Esaki M; Raju, Sivadoss.
Afiliação
  • Selvavinayagam ST; State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, 600 006, India.
  • Sankar S; Department of Microbiology, Centre for Infectious Diseases, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, 600 077, India.
  • Yong YK; Laboratory Center, Xiamen University Malaysia, 43900, Sepang, Selangor, Malaysia.
  • Murugesan A; Kelip-kelip! Center of Excellence for Light Enabling Technologies, Xiamen University Malaysia, 43900, Sepang, Selangor, Malaysia.
  • Suvaithenamudhan S; Department of Microbiology, Government Theni Medical College and Hospital, Theni, 625 512, India.
  • Hemashree K; Department of Bioinformatics, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620 024, India.
  • Rajeshkumar M; State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, 600 006, India.
  • Kumaresan A; State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, 600 006, India.
  • Pandey RP; State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, 600 006, India.
  • Shanmugam S; School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, 248 007, India.
  • Arthydevi P; Center for Infectious Diseases, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, 602 105, India.
  • Kumar MS; State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, 600 006, India.
  • Gopalan N; State Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, Teynampet, Chennai, Tamil Nadu, 600 006, India.
  • Kannan M; Department of Epidemiology and Public Health, Central University of Tamil Nadu, Thiruvarur, 610 005, India.
  • Cheedarla N; Blood and Vascular Biology, Department of Biotechnology, Central University of Tamil Nadu, Thiruvarur, 610 005, India.
  • Tan HY; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Division of Microbiology and Immunology, Emory National Primate Research Center, Emory Vaccine Center, Atlanta, GA, 30329, USA.
  • Zhang Y; School of Traditional Chinese Medicine, Xiamen University Malaysia, 43900, Sepang, Selangor, Malaysia.
  • Larsson M; Kelip-kelip! Center of Excellence for Light Enabling Technologies, Xiamen University Malaysia, 43900, Sepang, Selangor, Malaysia.
  • Balakrishnan P; Chemical Engineering, Xiamen University Malaysia, 43900, Sepang, Malaysia.
  • Velu V; Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, 58 185, Linköping, Sweden.
  • Byrareddy SN; Department of Research, Meenakshi Academy of Higher Education and Research (MAHER), Chennai, 600 078, India.
  • Shankar EM; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Division of Microbiology and Immunology, Emory National Primate Research Center, Emory Vaccine Center, Atlanta, GA, 30329, USA.
  • Raju S; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68131, USA.
Sci Rep ; 14(1): 17476, 2024 07 30.
Article em En | MEDLINE | ID: mdl-39080396
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Mutação Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Mutação Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article